A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 48/00 (2006.01) C12N 15/85 (2006.01)
Patent
CA 2580996
What is disclosed is the use of a formulation comprising double stranded ribonucleic acid (dsRNA) in the manufacture of a medicament for treating an inflammatory disease in a mammal and inhibiting production of tumor necrosis factor-.alpha. (TNF-.alpha.) in the mammal.
L'invention concerne l'utilisation d'une formulation contenant de l'acide ribonucléique bicaténaire (ARNds) dans la fabrication d'un médicament destiné à traiter une maladie inflammatoire chez un mammifère et à inhiber la production du facteur de nécrose tumorale a (TNF-a) chez le mammifère.
Chen Lishan
Chen Yuching
Cui Kunyuan
Houston Michael E. Jr.
Borden Ladner Gervais Llp
Mdrna Inc.
Nastech Pharmaceutical Company Inc.
LandOfFree
Method of treating an inflammatory disease by double... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating an inflammatory disease by double..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating an inflammatory disease by double... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1837640